Partner Dr Luke Kempton leads Wragge & Co life sciences team in licensing agreement
Wragge & Co’s life sciences team has brokered a licensing agreement between AstraZeneca and a partnership of Belgian life sciences research institutes: the Biotechnology Institute VIB, CD3 and KU Leuven. The deal will see AstraZeneca in-license certain novel molecules from VIB/CD3 and collaborate with academics to explore new insights into treatments for inflammatory and cancer […]